PubMed
open access
CC BY 4.0
High-throughput identification of bacterial β-glucuronidase inhibitors using machine learning.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Revolutionizing Drug Discovery: The Role of Artificial Intelligence in Accelerating Pharmaceutical Innovation"#105544
- Discovery of natural RORγt inhibitor using machine learning, virtual screening, and in vivo validation.#255444
- Advancing Drug Discovery with AI: Machine and Deep Learning Strategies for Target Identification and Precision Nanomedicine.#280961
- Deep Learning-Based Protein Half-Life Prediction for Identifying Rate-Limiting Enzymes in Metabolic Pathways to Alleviate Bottleneck Reactions.#148240
- Assay-Aware BindingDB: Curating Experimental Context for Binding Affinity Prediction#1119074
Record · ID 267109
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive